tiprankstipranks
Trending News
More News >
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB
US Market
Advertisement

PharmaCyte Biotech (PMCB) Technical Analysis

Compare
231 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
PharmaCyte Biotech’s (PMCB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting PharmaCyte Biotech is a Sell.
PharmaCyte Biotech’s (PMCB) 20-Day exponential moving average is 0.96, while PharmaCyte Biotech’s (PMCB) share price is $0.93, making it a Sell.
PharmaCyte Biotech’s (PMCB) 50-Day exponential moving average is 0.99, while PharmaCyte Biotech’s (PMCB) share price is $0.93, making it a Sell.

PharmaCyte Biotech (PMCB) Pivot Points

Sep 06, 2025, 01:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.86
0.89
0.93
0.96
0.99
1.02
1.06
Fibonacci
0.89
0.92
0.93
0.96
0.98
1.00
1.02
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmaCyte Biotech (PMCB) Moving Averages

Sep 06, 2025, 01:07 AM
Period
Simple
Exponential
MA5
0.94Sell
0.95Sell
MA10
0.96Sell
0.95Sell
MA20
0.93Sell
0.96Sell
MA50
1.00Sell
0.99Sell
MA100
1.05Sell
1.09Sell
MA200
1.33Sell
1.32Sell
PharmaCyte Biotech’s (PMCB) 10-Day exponential moving average is 0.95, while PharmaCyte Biotech’s (PMCB) share price is $0.93, making it a Sell.
PharmaCyte Biotech’s (PMCB) 100-Day exponential moving average is 1.09, while PharmaCyte Biotech’s (PMCB) share price is $0.93, making it a Sell.
PharmaCyte Biotech’s (PMCB) stock price is $0.93 and PharmaCyte Biotech’s (PMCB) 50-day simple moving average is 1.00, creating a Sell signal.
PharmaCyte Biotech’s (PMCB) stock price is $0.93 and PharmaCyte Biotech’s (PMCB) 100-day simple moving average is 1.05, creating a Sell signal.
PharmaCyte Biotech’s (PMCB) stock price is $0.93 and PharmaCyte Biotech’s (PMCB) 200-day simple moving average is 1.33, creating a Sell signal.

PharmaCyte Biotech (PMCB) Technical Indicators

Sep 06, 2025, 01:07 AM
Name
Value
Implied Action
RSI (14)
45.64
Neutral
STOCH (9,6)
16.27
Buy
STOCHRSI (14)
33.35
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
23.86
Neutral
Williams %R
-71.43
Buy
CCI (14)
9.89
Neutral
ATR (14)
0.08
-
Ultimate Oscillator
33.20
Neutral
ROC
4.49
Buy
PharmaCyte Biotech’s (PMCB) Relative Strength Index (RSI) is 45.64, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Trend Strength Indicator (ADX) is 23.86, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Commodity Channel Index (CCI) is 9.89, creating a Neutral signal.
PharmaCyte Biotech’s (PMCB) Price Rate of Change (ROC) is 4.49, creating a Buy signal.

FAQ

Is PMCB a Buy, Hold, or Sell?
Based on PMCB’s technical indicators, PMCB is a Sell.
    What is PMCB’s RSI (14)?
    PMCB’s RSI (14) is 45.64, which suggests PMCB is a Neutral.
      What is PMCB’s MACD?
      PMCB’s MACD is >-0.01, which suggests PMCB is a Sell.
        What is PMCB’s 5-day moving average?
        PMCB’s 5-day moving average is 0.94, which suggests PMCB is a Sell.
          What is PMCB’s 20-day moving average?
          PMCB 20-day moving average is 0.93, which suggests PMCB is a Sell.
            What is PMCB’s 50-day moving average?
            PMCB’s 50-day moving average is 1.00, which suggests PMCB is a Sell.
              What is PMCB’s 200-day moving average?
              PMCB’s 200-day moving average is 1.33, which suggests PMCB is a Sell.
                What is PMCB’s Williams % R (14)?
                PMCB’s Williams % R (14) is -71.43, which suggests PMCB is a Buy.
                  What is PMCB’s CCI (14)?
                  PMCB’s CCI (14) is 9.89, which suggests PMCB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis